Chemotherapy and/or immune checkpoint inhibitors in NSCLC first-line setting: what is the best approach?
Luigi Della GravaraCiro BattiloroRosa CantileAntonietta LetiziaFabiana VitielloVincenzo MontesarchioDanilo RoccoPublished in: Lung cancer management (2020)